ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 1 filers reported holding ONCOLYTICS BIOTECH INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,000 | -70.0% | 10,700 | -7.8% | 0.00% | -66.7% |
| Q2 2019 | $20,000 | -9.1% | 11,600 | 0.0% | 0.01% | -18.2% |
| Q1 2019 | $22,000 | +10.0% | 11,600 | +5.0% | 0.01% | -15.4% |
| Q4 2018 | $20,000 | -53.5% | 11,050 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $43,000 | – | 11,050 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SOPHROSYNE CAPITAL LLC | 222,900 | $345,000 | 0.30% |
| ACUITY INVESTMENT MANAGEMENT INC | 69,300 | $108,000 | 0.04% |
| VSR Financial Services, Inc. | 357,770 | $554,000 | 0.04% |
| 1832 Asset Management L.P. | 2,704,900 | $4,227,000 | 0.02% |
| Paradigm Financial Advisors, LLC | 9,558 | $15,000 | 0.02% |
| AGF INVESTMENTS INC. | 860,749 | $1,345,000 | 0.01% |
| BANK OF MONTREAL /CAN/ | 1,833,669 | $2,842,000 | 0.00% |
| BANK OF NOVA SCOTIA | 500,000 | $781,000 | 0.00% |
| RUSSELL FRANK CO/ | 1,005,900 | $1,553,000 | 0.00% |
| First Eagle Investment Management, LLC | 427,200 | $662,000 | 0.00% |